FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 329

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
IMDX Nasdaq Insight Molecular Diagnostics Inc. 2836
IMMX Nasdaq Immix Biopharma, Inc. 2836
IMNM Nasdaq Immunome, Inc. 2836
IMRN Nasdaq Immuron Limited 2836
IMTX Nasdaq Immatics N.V. 2836
IMVT Nasdaq Immunovant, Inc. 2836
INCY Nasdaq Incyte Corporation 2836
INKT Nasdaq MiNK Therapeutics, Inc. 2836
INM Nasdaq InMed Pharmaceuticals Inc. 2836
INMB Nasdaq INmune Bio, Inc. 2836
INO Nasdaq Inovio Pharmaceuticals, Inc. 2836
INSM Nasdaq Insmed Incorporated 2836
INTS Nasdaq Intensity Therapeutics, Inc. 2836
INZY Nasdaq Inozyme Pharma, Inc. 2836
IOVA Nasdaq Iovance Biotherapeutics, Inc. 2836
IPHA Nasdaq Innate Pharma S.A. 2836
IPSC Nasdaq Century Therapeutics, Inc. 2836
IRD Nasdaq Opus Genetics, Inc. 2836
IRWD Nasdaq Ironwood Pharmaceuticals, Inc. 2836
ITOS Nasdaq iTeos Therapeutics, Inc. 2836
JBIO Nasdaq Jade Biosciences, Inc. 2836
JSPR Nasdaq Jasper Therapeutics, Inc. 2836
KALV Nasdaq KalVista Pharmaceuticals, Inc. 2836
KLRS Nasdaq Kalaris Therapeutics, Inc. 2836
KLTO Nasdaq Klotho Neurosciences, Inc. 2836
KMDA Nasdaq Kamada Ltd. 2836
KROS Nasdaq Keros Therapeutics, Inc. 2836
KRRO Nasdaq Korro Bio, Inc. 2836
KRYS Nasdaq Krystal Biotech, Inc. 2836
KYTX Nasdaq Kyverna Therapeutics, Inc. 2836
LADX Over the counter LadRx Corporation 2836
LEGN Nasdaq Legend Biotech Corporation 2836
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2836
LGVN Nasdaq Longeveron Inc. 2836
LMAT Nasdaq LeMaitre Vascular, Inc. 2836
LPTX Nasdaq Leap Therapeutics, Inc. 2836
LRMR Nasdaq Larimar Therapeutics, Inc. 2836
LSB Nasdaq LakeShore Biopharma Co., Ltd 2836
LYEL Nasdaq Lyell Immunopharma, Inc. 2836
LYRA Nasdaq Lyra Therapeutics, Inc. 2836
MBIO Nasdaq Mustang Bio, Inc. 2836
MBX Nasdaq MBX Biosciences, Inc. 2836
MCRB Nasdaq Seres Therapeutics, Inc. 2836
MDXG Nasdaq MiMedx Group, Inc. 2836
MGNX Nasdaq MacroGenics, Inc. 2836
MGTX Nasdaq MeiraGTx Holdings plc 2836
MNKD Nasdaq MannKind Corporation 2836
MNOV Nasdaq MediciNova, Inc. 2836
MNPR Nasdaq Monopar Therapeutics Inc. 2836
MOLN Nasdaq Molecular Partners AG 2836
Results 150 through 200 of 329